These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1045 related articles for article (PubMed ID: 6378975)

  • 41. Lipolysis-induced partitioning of free fatty acids to lipoproteins: effect on the biological properties of free fatty acids.
    Chung BH; Tallis GA; Cho BH; Segrest JP; Henkin Y
    J Lipid Res; 1995 Sep; 36(9):1956-70. PubMed ID: 8558084
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of colestipol on the metabolism of very-low-density lipoproteins in man.
    Witztum JL; Schonfeld G; Weidman SW
    J Lab Clin Med; 1976 Dec; 88(6):1008-18. PubMed ID: 186544
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The transport of triglyceride in the high-density lipoproteins of human plasma.
    Barter PJ; Connor WE
    J Lab Clin Med; 1975 Feb; 85(2):260-72. PubMed ID: 163284
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cholesteryl ester transfer activity. Localization and role in distribution of cholesteryl ester among lipoproteins in man.
    Groener JE; Van Rozen AJ; Erkelens DW
    Atherosclerosis; 1984 Mar; 50(3):261-71. PubMed ID: 6712775
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects.
    Packard CJ; Munro A; Lorimer AR; Gotto AM; Shepherd J
    J Clin Invest; 1984 Dec; 74(6):2178-92. PubMed ID: 6511922
    [TBL] [Abstract][Full Text] [Related]  

  • 46. VLDL triglycerides inhibit HDL-associated paraoxonase 1 (PON1) activity: in vitro and in vivo studies.
    Rosenblat M; Ward S; Volkova N; Hayek T; Aviram M
    Biofactors; 2012; 38(4):292-9. PubMed ID: 22674772
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationships of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction.
    Tornvall P; Karpe F; Carlson LA; Hamsten A
    Atherosclerosis; 1991 Sep; 90(1):67-80. PubMed ID: 1799399
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of slow-release bezafibrate on serum lipids, lipoproteins, apolipoproteins, and postheparin lipolytic activities in patients with type IV and type V hypertriglyceridemia.
    Saku K; Sasaki J; Arakawa K
    Clin Ther; 1989; 11(3):331-40. PubMed ID: 2743372
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The plasma lipoproteins in familial chylomicronemia. Analysis by zonal ultracentrifugation.
    Manzato E; Marin R; Gasparotto A; Baggio G; Fellin R; Crepaldi G
    J Lab Clin Med; 1984 Nov; 104(5):778-88. PubMed ID: 6491471
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of cigarette smoke and dietary cholesterol on plasma lipoprotein composition.
    Hojnacki JL; Mulligan JJ; Cluette JE; Kew RR; Stack DJ; Huber GL
    Artery; 1981; 9(4):285-304. PubMed ID: 7316779
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Study on lipid and apolipoprotein composition of plasma VLDL, LDL and HDL in endogenous hypertriglyceridemia].
    Fan P; Liu B
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Mar; 26(1):6-10. PubMed ID: 7657341
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanism of action of gemfibrozil on lipoprotein metabolism.
    Saku K; Gartside PS; Hynd BA; Kashyap ML
    J Clin Invest; 1985 May; 75(5):1702-12. PubMed ID: 3923042
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of dietary lipids on hepatic mRNA levels of proteins regulating plasma lipoproteins in baboons with high and low levels of large high density lipoproteins.
    Kushwaha RS; McMahan CA; Mott GE; Carey KD; Reardon CA; Getz GS; McGill HC
    J Lipid Res; 1991 Dec; 32(12):1929-40. PubMed ID: 1687745
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding.
    de Man FH; de Beer F; van der Laarse A; Jansen H; Leuven JA; Souverijn JH; Vroom TF; Schoormans SC; Fruchart JC; Havekes LM; Smelt AH
    Atherosclerosis; 2000 Dec; 153(2):363-71. PubMed ID: 11164425
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia.
    Mann CJ; Yen FT; Grant AM; Bihain BE
    J Clin Invest; 1991 Dec; 88(6):2059-66. PubMed ID: 1752964
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lack of effect of tocopherol on plasma lipids and lipoproteins in man.
    Kesaniemi YA; Grundy SM
    Am J Clin Nutr; 1982 Aug; 36(2):224-8. PubMed ID: 7102581
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changes in high density lipoprotein subfraction lipids during neutral lipid transfer in healthy subjects and in patients with insulin-dependent diabetes mellitus.
    Ritter MC; Bagdade JD
    Lipids; 1996 Jan; 31(1):1-7. PubMed ID: 8649226
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Uptake of type IV hypertriglyceridemic VLDL by cultured macrophages is enhanced by interferon-gamma.
    Whitman SC; Argmann CA; Sawyez CG; Miller DB; Hegele RA; Huff MW
    J Lipid Res; 1999 Jun; 40(6):1017-28. PubMed ID: 10357833
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential distribution of sphingomyelins among plasma lipoprotein classes.
    Myher JJ; Kuksis A; Breckenridge WC; Little JA
    Can J Biochem; 1981 Aug; 59(8):626-36. PubMed ID: 7296345
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impaired lipoprotein processing in HIV patients on antiretroviral therapy: aberrant high-density lipoprotein lipids, stability, and function.
    Gillard BK; Raya JL; Ruiz-Esponda R; Iyer D; Coraza I; Balasubramanyam A; Pownall HJ
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1714-21. PubMed ID: 23640486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.